|
Volumn 58, Issue SUPPL. 10, 1997, Pages 13-17
|
Safety of olanzapine
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
BENZATROPINE MESILATE;
CLOZAPINE;
HALOPERIDOL;
LORAZEPAM;
NEUROLEPTIC AGENT;
OLANZAPINE;
PLACEBO;
AKATHISIA;
ANOREXIA;
ARTICLE;
BLOOD TOXICITY;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELUSION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG SAFETY;
DYSTONIA;
HUMAN;
MAJOR CLINICAL STUDY;
PARESTHESIA;
PARKINSONISM;
PHARYNGITIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
SEIZURE;
SOCIAL DISABILITY;
VERTIGO;
WEIGHT GAIN;
ACUTE DISEASE;
AKATHISIA, DRUG-INDUCED;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BLOOD PRESSURE;
CLINICAL TRIALS;
CROSS-OVER STUDIES;
DIZZINESS;
DOUBLE-BLIND METHOD;
DYSTONIA;
HALOPERIDOL;
HEART RATE;
HUMANS;
LIVER;
PARKINSON DISEASE, SECONDARY;
PIRENZEPINE;
PLACEBOS;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SLEEP;
TRANSAMINASES;
TREATMENT OUTCOME;
WEIGHT GAIN;
|
EID: 1842301026
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (235)
|
References (8)
|